Skip to content

Clinical trials

Phase 1 Adenocarcinoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 1 Country / region: Japan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20201
20211
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation2
Eli Lilly and Company2
Astellas Pharma Global Development, Inc.1
Elevation Oncology1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma9
Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Neoplasms by Site4
Lung Neoplasms3
Bronchial Neoplasms2
Carcinoma2
Carcinoma, Bronchogenic2
Digestive System Neoplasms2
Lung Diseases2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.